Curis, Inc. (CRIS) vs Propanc Biopharma, Inc. (PPCB)

A side-by-side comparison of Curis, Inc. and Propanc Biopharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Curis, Inc. logo
CRIS
Curis, Inc.
$1M
$0.75HealthcareDelayed quote: Oct 6, 2026, 12:52 PM EDT
Propanc Biopharma, Inc. logo
PPCB
Propanc Biopharma, Inc.
$1M
$0.50HealthcareDelayed quote: Oct 6, 2026, 12:38 PM EDT

Total return — CRIS vs PPCB

growth of $100 · dividends reinvested · last 10y
CRIS -99.5% (-41.0%/yr)PPCB -100.0% (-89.4%/yr)CRIS compounded faster over this window
Log scale — wide-divergence pair
000000001101001kStart $10020172019202120232025$1$0
CRIS PPCB

CRIS vs PPCB: by the numbers

  • •CRIS is the larger company ($1M vs $1M market cap).
  • •Both run net losses; PPCB's is the smaller (0.00% vs -490.33% net margin).

Metrics side by side

Valuation

MetricCRISPPCB
P/S ratio0.34N/A
P/B ratio0.310.12

Profitability

MetricCRISPPCB
Gross margin99.28%0.00%
Operating margin-348.43%0.00%
Net margin-490.33%0.00%
ROE-450.54%-200.63%
ROIC-567.17%-183.49%

Growth (annualized)

MetricCRISPPCB
Revenue CAGR (5Y)-15.88%N/A
Total return CAGR (5Y)-81.06%N/A

Go deeper

Full CRIS analysisFull PPCB analysisInteractive comparison tool

Dig into the metrics

Curis ROEPropanc Biopharma ROECuris operating marginPropanc Biopharma operating marginCuris revenue growthPropanc Biopharma revenue growthCuris free cash flowPropanc Biopharma free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.